| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3044483 | Clinical Neurophysiology | 2011 | 5 Pages |
ObjectiveCervical dystonia (CD) lacks an objective quantitative measure. Electrical impedance myography (EIM) is a non-invasive assessment method sensitive to changes in muscle structure and physiology. We evaluate the potential role of EIM in quantifying CD, hypothesizing that patients would demonstrate differences in the symmetry of muscle electrical resistance compared to controls, and that this asymmetry would decrease after botulinum neurotoxin (BoNT) treatment.MethodsEIM was performed on the sternocleidomastoid (SCM) and cervical paraspinal (PS) muscles of CD patients and age-matched controls. 50 kHz resistance was analyzed, comparing side-to-side asymmetry in patients and controls, and, in patients, before and after BoNT treatment.ResultsSixteen patients and 10 controls were included. Resistance asymmetry was on average 3–5 times higher in patients than controls. Receiver operating characteristic analysis demonstrated 91% accuracy of discriminating CD from normal. From pre-treatment to maximum BoNT effect, asymmetry decreased from 20.8(13.9–26.1)% to 6.2(3.1–9.9)% (SCM), and from 16.0(14.3–16.0)% to 8.4(7.0–9.2)% (PS), p < 0.05 (median, interquartile range).ConclusionsEIM effectively differentiates normal subjects from CD patients by revealing asymmetries in resistance values and detects improvement in muscle symmetry after treatment.SignificanceThese results suggest that EIM, a painless, non-invasive measure, can provide a useful quantitative metric in CD evaluation and deserves further study.
